-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on September 23, 2026, Federal Biotech has received US$9 million from Novo Pay for the global phase I clinical milestone payment for UBT251 injection for type 2 diabetes indications (after deducting Danish withholding tax).
Share
Listen to the news
Zhitong Finance App News, Federal Pharmaceuticals (03933.HK) announced that on September 23, 2026, Federal Biotech has received US$9 million from Novo Pay for the global phase I clinical milestone payment for UBT251 injection for type 2 diabetes indications (after deducting Danish withholding tax).
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending